
News|Articles|June 26, 2026
5 Essential Capabilities for Decentralized Clinical Trials
Author(s)Quest Diagnostics
Key Takeaways
- Decentralized clinical trials are positioned as a foundational competency as clinical research continues shifting toward broader access and real-world evidence generation.
- Expanded participation is enabled by reducing geographic and logistical barriers for patients, supporting more inclusive enrollment and retention.
Advertisement
As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, enabling broader patient participation, increasing trial efficiency, and driving more inclusive, real-world data collection. However, the successful execution of DCTs requires more than just innovative technology—it demands a comprehensive strategy that addresses the unique challenges of decentralization.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
2
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
3
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
4
Bridging Data Gaps: Curating Real-World Data for Oncology Research
5



